Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ambrx Biopharma Inc ADR (AMAM)

Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson

These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?

KVUE : 18.27 (-0.27%)
AMAM : 28.00 (+0.07%)
UNH : 567.64 (+0.58%)
JNJ : 154.54 (-0.57%)
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

ONCY : 1.0365 (+0.63%)
ONC.TO : 1.40 (-2.10%)
AMGN : 330.32 (-0.20%)
AMAM : 28.00 (+0.07%)
ELEV : 2.73 (+2.25%)
NKTX : 6.45 (-3.01%)
Johnson & Johnson: Biotech a shot in the arm for future growth?

Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.

JNJ : 154.54 (-0.57%)
AMAM : 28.00 (+0.07%)
Markets Today: Stocks Edge Higher on Hopes Israeli-Hamas Conflict Can Be Contained

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.38%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.22%. Stock index futures this morning are moderately higher as the markets...

ESU24 : 5,564.75 (-0.53%)
NQU24 : 19,776.00 (-0.62%)
LULU : 282.60 (-0.89%)
HUBB : 374.23 (+1.48%)
VFS : 4.55 (-0.22%)
ALSN : 83.98 (+0.16%)
DXCM : 110.96 (+0.23%)
CL : 98.30 (+0.30%)
CART : 35.33 (+0.94%)
AMAM : 28.00 (+0.07%)
AAPL : 224.80 (+0.28%)
PFE : 29.74 (+0.10%)
Why Shares of Ambrx Biopharma Soared This Week

A big buy by an asset manager spurred interest in the biotech stock.

AMAM : 28.00 (+0.07%)
Why Shares of Ambrx Biopharma Jumped This Week

The company reported data on its clinical programs at two conferences this week.

RY : 111.14 (-0.84%)
RY.TO : 152.51 (-0.81%)
AMAM : 28.00 (+0.07%)
Ambrx Raises $78 Million and Completes its ATM Program

Ambrx Biopharma Inc., or Ambrx (NYSE: AMAM), today announced that it has completed net sales of approximately $78 million of American Depositary Shares (“ADSs”) pursuant to the Company’s at-the-market...

AMAM : 28.00 (+0.07%)
Why Shares of Ambrx Biopharma Fell Tuesday

After getting a bump on Monday for its switch to the Nasdaq Stock Market, there was a bit of a correction.

AMAM : 28.00 (+0.07%)
Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy

Ambrx Pharmaceuticals, Inc. could see positive earnings next year. And while share value could go down, analysts thin rate AMAM a Moderate Buy

AMAM : 28.00 (+0.07%)
MOLN : 6.58 (+0.94%)
Ambrx to Commence Trading on Nasdaq

Ambrx Biopharma Inc. (NYSE: AMAM ) (“Ambrx” or “the Company”) today announced that it will voluntarily transfer its stock exchange listing to the Nasdaq Stock Market from the New York Stock Exchange,...

AMAM : 28.00 (+0.07%)

Barchart Exclusives

Will Gold Keep Making Higher Record Highs?
Gold rose to a new record high in Q2 2024 and in early Q3. The precious metal looks set to make even higher highs during the second half of this year. Gold is the world’s oldest currency, and as inflation erodes fiat foreign exchange instruments and the international financial system has turned from U.S. dollar dominance, the sky could be the limit for gold prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar